Wire flash
FinancePhilip Morris doubles Colorado Zyn investment to $1.2 billion
Editorial responsibility
- No named human review is recorded for this page.
- Source reporting is collected, normalized, translated or condensed automatically when needed.
- Automatically published source-backed update
Philip Morris International Inc. announced a significant increase in its investment in U.S. nicotine pouch production, committing $1.2 billion to its manufacturing facility in Aurora, Colorado, by 2028. This doubles the $600 million pledged in 2024, driven by growing demand for smoke-free nicotine products. The Aurora facility has begun operations and will expand production of Zyn nicotine pouches, including the new Zyn Ultra variant introduced in June 2026, which features a softer pouch design and higher nicotine strength. The investment comes amid rising competition from British American Tobacco's Velo Plus. Beyond the U.S. market, the facility will also produce Zyn for export to Asia, Latin America, and the Caribbean, supporting Philip Morris's international expansion strategy as it reduces reliance on traditional cigarettes.
Source report
Fiona Craig Mon, July 27, 2026 at 6:30 AM PDT 2 min read
- PM +2.31%
- BTI +2.43%
Philip Morris International Inc. (NYSE:PM) is significantly increasing its investment in U.S. nicotine pouch production, announcing plans to commit $1.2 billion to its manufacturing facility in Aurora, Colorado, by 2028.
The revised investment doubles the $600 million the company pledged in 2024 and reflects growing demand for smoke-free nicotine products.
Zyn Production Ramps Up Amid Rising Competition
The Aurora facility, located just outside Denver, has recently begun manufacturing operations and will play a key role in expanding production of Zyn nicotine pouches.
Philip Morris is strengthening its manufacturing footprint as competition intensifies in the nicotine pouch market, where rival products such as British American Tobacco Plc's Velo Plus are seeking to gain market share.
Smoke-Free Products Remain a Strategic Priority
Zyn has become a cornerstone of Philip Morris' strategy to reduce its reliance on traditional cigarettes as consumers increasingly shift toward smoke-free alternatives.
Although the brand continues to lead the nicotine pouch segment, new products entering the market have increased competitive pressure.
The expanded Colorado facility will support higher production volumes of Zyn Ultra, the latest version of the product introduced in the United States in June.
New Product Designed for Evolving Consumer Preferences
Zyn Ultra offers a softer pouch design and higher nicotine strength, features intended to meet changing consumer demand.
It is the first major update to the Zyn product line since the original version was introduced a decade ago, with Philip Morris delaying new product launches while awaiting approval from the U.S. Food and Drug Administration.
Beyond supplying the U.S. market, the Aurora manufacturing campus will also produce Zyn products for export to customers across Asia, Latin America, and the Caribbean, supporting the company's broader international expansion plans.
Philip Morris International stock price
View Comments
Source
Yahoo FinanceWestern
Part of this Story
Philip Morris expands Colorado Zyn investment to $1.2 billion